Pictured: Lisa Chapuran, Mary Hughes, Mariam Parizad, Leslie Smoot
CCI Clinical Trials Team Serves Cancer Patients Near, Far
(May 20, 2022)-The team at Clearview Cancer Institute has been involved in cancer research for more than three decades. We have a department dedicated to research and clinical trials. Our commitment remains with new targeted therapies, better detection methods, genomic testing and personalized medicine.
Did you know:
- The CCI research team has participated in the FDA approval of the following medications: Herceptin, Avastin, Rituxan and more.
- The CCI research team has a combined 30 years experience in research including 4 RNs that serve as study coordinators, a regulatory/investigational product coordinator, and a lab and registry coordinator.
- Clinical trials have improved childhood cancer survival from less than 10% to 80% survival.
- Clinical trials can allow access to therapies that are up and coming and not available otherwise.
- Developing new medicine takes at least 10 years on average to receive FDA approval.
- Clinical trials look at new ways to prevent, detect, or treat disease.
- Groundbreaking scientific advances in the present and the past were possible only because of participation of volunteers, both healthy and those diagnosed with an illness, in clinical research.
A special thanks to these physicians who serve as primary investigators:
Dr. Paul Dang
Dr. Jorge Diaz
Dr. Kanth Katragadda
Dr. Brian Mathews
Dr. Daniel Schreeder
Dr. Marshall Schreeder
Patient Portal Notice
Clearview Cancer Institute has started using a new patient portal, called Noona, in order to better connect patients with their care team.
If you have an email address on file, be on the lookout for an invitation email to sign up. Your care team can also help you register during your next visit. CareSpace will be available for a limited time.